VideoCannabisPodcastsTrade To Black

Margaret Brodie On Rubicon Organics’ Deal With Medipharm

By Shadd Dales On Mar 6, 2025

On our latest Trade To Black Podcast, hosts Shadd Dales and Anthony Varrell welcome in Rubicon Organics’ CEO, Margaret Brodie, to discuss the company’s latest moves in the cannabis sector and the deal with Medipharm. Plus, Seth Yakatan, a cannabis investor and advisor, joins to analyze cannabis earnings. Highlights include Green Thumb Industries (OTCQX: GTI)’s strong performance, Trulieve (OTCQX: TCNNF)’s positive results and management rumors, Curaleaf (OTCQX: CURLF) still losing money under Boris Jordan’s watch, and Glass House (OTC: GLASSF)’s record-low-rate bank deal.

Margaret Brodie gives us the news that Rubicon Organics (OTCQX: ROMJF) has entered a purchase and sale agreement with Medipharm Labs Inc. Rubicon is acquiring a 47,500-square-foot indoor cultivation facility in Hope, British Columbia, valued at $4.5 million CAD.

She highlights how organic cultivation enhances cannabis quality, likening it to the difference between mass-produced grocery store strawberries and garden-grown fruit. Brodie explains how Rubicon is doubling down on the Canadian market, seeing premium products as the future of the industry. She also touches on the international demand for high-quality cannabis and how Rubicon’s expansion allows them to serve both domestic and international markets. This facility, with an estimated $12 million replacement cost, marks a significant move for Rubicon Organics as they solidify their foothold in the Canadian cannabis market.

We’ll also discuss the Canadian cannabis market’s 2025 outlook. Topics include how the OSC favors companies focusing on premium products and domestic markets, and the challenges licensed producers face when re-entering the Canadian market after shifting attention internationally.

In the markets, GTI continues to stand out, posting strong revenue and a $43 million share buyback, solidifying its position as an industry leader. Trulieve reported solid margins and a positive quarter. Verano, on the other hand, struggled with a $273 million net loss, missing estimates and facing price compression in key states like Illinois, New York, and New Jersey.

Glass House Brands’ has what Yakutin calls the best financing deal in cannabis in years, crediting CEO Kyle Kazan and the team for securing unmatched terms. Additionally, The Cannabist Company secured a long-term debt extension until 2029, allowing them to focus on execution rather than short-term financial pressure. Get all the details when you tune in.

AN – Sidebar Square

Shadd Dales

Shadd Dales is the Founder and President of The Dales Report and has an extensive background in the business media industry.

His work translates into over 15 years in mainstream media that included roles with BNN Bloomberg, CTV Properties and the iHeart Radio Network.

Shadd is considered one of the leading on air talents in both the cannabis and psychedelic space and has interviewed some of the most notable CEO names in the industry.

Shadd’s vision is to establish a content platform that is equivalent to a mainstream broadcast produced in a format that is relevant for today’s investor.